The influence of formulation on drug action
Münzel, K.
Pharmaceutica Acta Helvetiae 46(9): 513-538
1971
ISSN/ISBN: 0031-6865 PMID: 5099398 Document Number: 41506
Document emailed within 1 workday
Related Documents
Svirskis, D.; Lin, S.-W.; Brown, H.; Sangaroomthong, A.; Shin, D.; Wang, Z.; Xu, H.; Dean, R.; Vareed, P.; Jensen, M.; Wu, Z. 2018: The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions International Journal of Pharmaceutical Compounding 22(2): 164-171Bittner, B.; Mountfield, R.J. 2002: Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters Current Opinion in Drug Discovery and Development 5(1): 59-71
Ferrari, M.; Olivieri, M.; Romito, D.; Biasin, C.; Barozzi, E.; Bassetti, S. 1991: Influence of gastric pH changes on pharmacokinetic of a sustained-release formulation of theophylline Rivista Europea Per le Scienze Mediche e Farmacologiche 13(5-6): 269-274
Sitges-Serra, A.; Gil Egea, M.J.; Martínez Ródenas, F. 1988: The influence of TPN formulation on the metabolic response to pre-operative refeeding in depleted patients British Journal of Clinical Practice. Supplement 63: 133-137
Farriol, M.; Orta, X. 2005: Influence of reagent formulation on mRNA quantification by RT-PCR using imported external standard curves Acta Biochimica Polonica 52(4): 845-848
Zhou, J.; Jiang, X.-H. 2019: Formulation conditions on the drug loading properties of polymeric micelles Pakistan Journal of Pharmaceutical Sciences 32(2): 607-615
Szabó, B.ás.; Hetényi, G.; Majoros, K.; Miszori, V.; Kállai, N.; Zelkó, R.án. 2011: Formulation aspects and ex-vivo examination of buccal drug delivery systems Acta Pharmaceutica Hungarica 81(4): 165-172
Junginger, H.E. 1992: Formulation aspects on dermatological preparations and transdermal drug delivery systems Acta Pharmaceutica Nordica 4(2): 117
Ronchi, C.; Burinato, C.; Zanol, M.; Borsa, M. 1986: Optimization of a formulation for parenteral use containing a thermolabile drug, and evaluation of possible steam sterilization Bollettino Chimico Farmaceutico 125(4): 93-99
2002: Tobramycin for nebulisation: new formulation. A high price for a small improvement in formulation Prescrire International 11(62): 177-178
2003: Sublingual selegiline: new formulation. New formulation: new risk of oral adverse effects Prescrire International 12(67): 179
Sahoo, S.K.; Sahoo, S.K.; Behera, A.; Patil, S.V.; Panda, S.K. 2013: Formulation, in vitro drug release study and anticancer activity of 5-fluorouracil loaded gellan gum microbeads Acta Poloniae Pharmaceutica 70(1): 123-127
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194
Steinijans, V.W.; Trautmann, H.; Sauter, R.; Staudinger, H. 1988: Theophylline therapeutic drug monitoring in the case of a new sustained-release pellet formulation for once-daily evening administration Arzneimittel-Forschung 38(8a): 1251-1253
Bozzay, J.; Békefi, E.; Dávid, A.; Rusznák, I. 1983: Data for the modeling of drug-receptor interaction, taking into consideration additives or combined active ingredients in the formulation Acta Pharmaceutica Hungarica 53(3): 97-105
Wang, Y.J.; Leesman, G.D.; Lipstein, M.E.; Basch, H.I.; Monkhouse, D.C. 1984: Optimization of autoclave cycles and selection of formulation for parenteral products, Part III: Effect of formulation variables on sporicidal kinetics Journal of parenteral science and technology: a publication of the Parenteral Drug Association 38(2): 78-82
Møllgaard, B.; Hoelgaard, A. 1983: Vehicle effect on topical drug delivery. I. Influence of glycols and drug concentration on skin transport Acta Pharmaceutica Suecica 20(6): 433-442
Schwabe, U. 1980: The influence of the drug legislation on drug information for the physician and patient Der Internist 21(6): 311-317
Knapp, D.E.; Crosby, D.L.; Brandon, B.M.; Knapp, D.A. 1978: Can pharmacists influence drug prescribing? a look at eight of the top 25 drug products for 1976 American Journal of Hospital Pharmacy 35(5): 593-594
Soni, S.D.; Tench, D.; Ashwood, T.J.; Movin, G. 1990: Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics Acta Psychiatrica Scandinavica. Supplementum 358: 45-47